Earnings History Data for Janux Therapeutics, Inc. (JANX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Janux Therapeutics, Inc.
Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies. Janux Therapeutics Inc. is based in LA JOLLA, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-08-2024 | PM | JANX | Janux Therapeutics | 1,930 | -0.11 | -0.32 | 0.00 | Janux Therapeutics GAAP EPS of -$0.11 beats by $0.21, revenue of $8.89M beats by $8.03M [8/8/2024 1:46 AM] |
36.39 | 1.10 (3.12%) |
37.06 | 1.77 (5.02%) |
5.65 - 65.60 | 737,030 | 610,000 | 422 | ||
| 07-05-2024 | AH | JANX | Janux Therapeutics | 3,359 | -0.30 | -0.35 | 0.00 | Janux Therapeutics GAAP EPS of -$0.30 beats by $0.03 [5/7/2024 5:59 PM] |
55.40 | -6.10 (-9.92%) |
52.00 | -9.50 (-15.45%) |
5.65 - 65.60 | 1,416,970 | 840,000 | 34,860 | ||
| 07-11-2023 | PM | JANX | Janux Therapeutics | 312.00 | -0.25 | -0.46 | 0.00 | Janux Therapeutics GAAP EPS of -$0.25 [11/8/2023 9:20 AM] |
6.62 | 0.06 (0.91%) |
6.61 | 0.05 (0.76%) |
5.74 - 23.64 | 159,979 | 100,000 | 438 | ||
| 10-03-2023 | AH | 4:00 PM ET (Mar 10) |
JANX | Janux Therapeutics | 657.00 | -0.39 | -0.45 | 0.00 | Janux Therapeutics GAAP EPS of -$0.39 beats by $0.10, revenue of $2.85M beats by $2.04M [3/10/2023 4:37 PM] |
13.73 | -0.36 (-2.56%) |
14.00 | -0.09 (-0.64%) |
9.39 - 23.64 | 63,690 | 70,000 | 11,127 | |
|
|
||||||||||||||||||
| 10-11-2022 | AH | JANX | Janux Therapeutics | 713.00 | -0.40 | -0.51 | 0.00 | Janux Therapeutics GAAP EPS of -$0.40, revenue of $1.8M [11/10/2022 4:52 PM] |
17.75 | 0.80 (4.72%) |
16.95 | 0.0 (0.00%) |
9.39 - 25.71 | 61,769 | 160,000 | 118 | ||
| 10-05-2022 | AH | 4:00 PM ET (May 10) |
JANX | Janux Therapeutics | 422.00 | -0.32 | -0.37 | 0.00 | Janux Therapeutics GAAP EPS of -$0.32 beats by $0.05, revenue of $1.59M beats by $0.78M [5/10/2022 5:51 PM] |
10.38 | 0.16 (1.57%) |
10.38 | 0.16 (1.57%) |
9.39 - 37.99 | 86,088 | 100,000 | 1,154 | |
| 18-03-2022 | AH | JANX | Janux Therapeutics | 713.00 | -0.33 | -0.30 | 0.00 | Janux Therapeutics GAAP EPS of -$0.33 misses by $0.02, revenue of $1.62M beats by $0.97M [3/18/2022 4:06 PM] |
15.28 | -1.58 (-9.37%) |
16.86 | 0.0 (0.00%) |
13.25 - 37.99 | 98,097 | 91,788 | 89,532 | ||